Latest News Archive
Please select Category, Year, and then Month to display items
18 October 2021
|
Story Dr Nitha Ramnath
Our podcast guest
Prof Jeandrew Brink holds the post of Associate Professor in the Department of Mathematics and Applied
Mathematics within the Faculty of Natural and Agricultural Sciences at the University of the Free State. Her areas of interest include an analytical interest in Einstein field equations, dynamical systems, algorithms for testing general relativity
and the no-hair theorems, black holes, and gravitational waves. Prof Brink registered for a Bachelor of Sciences in 1998, continued with honours studies in 1999, and completed her master’s degree in 2000. Prof Brink’s research is on various
theoretical aspects of testing general relativity. She is a member of the MeerKAT telescope team that times and detect pulsars. She is also working with members of the Laser Interferometer Gravitational-Wave Observatory (LIGO) to find ways of using
gravitational waves to test Einstein’s theory.
Prof Brink was involved in the compilation of a video of geodesic orbits around a Manko-Novikov singularity, selected to be part of a Starmus 3 concert, the proceeds of which went towards promoting the Stephen Hawking Medal for Science Communication and
to support the charitable activities of the Stephen Hawking Foundation. It could also be part of a subsequent documentary.
Listen to the podcast at
François van Schalkwyk and Keenan Carelse,
UFS alumni leading the university’s United
Kingdom Alumni Chapter, have put their voices together to produce and direct the podcast series. Intended to reconnect alumni with the university and their university experience, the podcasts will be featured on the first Monday of every month,
ending in November 2021. Our featured alumni share and reflect on their experiences at the UFS, how it has shaped their lives, and relate why their ongoing association with the UFS is still relevant and important. The podcasts are authentic
conversations – they provide an opportunity for the university to understand and learn about the experiences of its alumni and to celebrate the diversity and touchpoints that unite them.
For further information regarding the podcast series, or to propose other alumni guests, please email us at
alumnipodcast@ufs.ac.za
For all Voices from the Free State podcasts,
click here.
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004